Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Suspended
300 enrolled
Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer
Phase 2 Suspended
80 enrolled
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
Phase 2/3 Suspended
928 enrolled
Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer
Phase NA Suspended
350 enrolled
LoTam
Phase 3 Suspended
1,156 enrolled
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
Phase NA Suspended
5,200 enrolled
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Phase 1/2 Suspended
29 enrolled
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
Phase 1 Suspended
20 enrolled
Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca
Phase 2 Suspended
48 enrolled
CRYOMATASE
Phase NA Suspended
70 enrolled
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Phase 1 Suspended
98 enrolled
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer
Suspended
15 enrolled
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
Suspended
500 enrolled
MIRROR
Suspended
20 enrolled
Physiotherapy Program Impact on Breast Cancer-Related Lymphedema
Phase NA Suspended
21 enrolled
Adherence Intervention in Patients With Metastatic Breast Cancer
Phase NA Suspended
35 enrolled
IPT
Phase 3 Suspended
20 enrolled
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Phase 2 Suspended
61 enrolled
RNSM
Phase NA Suspended
30 enrolled
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment
Suspended
10 enrolled
IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors
Phase 1 Suspended
135 enrolled
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer
Phase 3 Suspended
201 enrolled 19 charts
Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer
Suspended
1,694 enrolled
DIRECT-2
Phase 3 Suspended
10 enrolled
Guangzhou Women's Health Cohort Study (GWHCS)
Suspended
1,000,000 enrolled
Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery
Phase NA Suspended
36 enrolled
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Phase 2 Suspended
170 enrolled
Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile
Suspended
20 enrolled
Guide for Prioritisation of Patients for Referral to Breast Clinics
Suspended
4,000 enrolled
Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.
Suspended
2,000 enrolled
PIKHER2
Phase 1/2 Suspended
106 enrolled
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Phase 1 Suspended
26 enrolled
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
Phase 1/2 Suspended
30 enrolled